A detailed history of Concourse Financial Group Securities, Inc. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,000 shares of ORMP stock, worth $2,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$2,370
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

BUY
$12.13 - $23.82 $12,130 - $23,820
1,000 New
1,000 $22,000
Q2 2021

Aug 13, 2021

BUY
$8.34 - $14.59 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$4.22 - $11.33 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$2.48 - $4.64 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.58 - $4.16 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$2.87 - $4.12 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020

BUY
$2.6 - $5.5 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.43 - $5.74 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$2.88 - $3.96 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$2.88 - $4.36 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$2.95 - $3.64 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$3.0 - $4.94 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$4.64 - $7.11 $0 - $0
0 New
0 $0

Others Institutions Holding ORMP

About ORAMED PHARMACEUTICALS INC.


  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.